Jean-Rene Fourtou, of drug multinational Aventis, has taken up the reins. His first task will be securing £1.5bn short-term finance and setting out a new strategy to restore rock-bottom confidence. Radical surgery is likely, but in a time of such uncertainty the task looks huge.